Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ferrologix is a private U.S. life science tools company that developed magnetic-based cell separation and sorting technology for precision medicine research, diagnostics, and cellular therapy manufacturing. The company emerged from the University of California, Los Angeles bioengineering ecosystem and built a platform centered on Digital Magnetic Sorting, using micro-magnetic substrates and disposable cartridges to transport, filter, organize, and purify magnetically tagged cells. Ferrologix appears to have operated primarily as a tools and platform company rather than a therapeutic drug developer, so it does not have a conventional drug pipeline with molecular targets or disease-specific clinical programs. Public company databases and private market sources indicate the business was founded in 2015 in Carlsbad, California and later backed through non-dilutive/accelerator support including BioTools Innovator and the National Science Foundation. Although some directories still list it as active, more recent private-market data indicate Ferrologix was out of business by late 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferrologix.